OHSU Rare Disease Research Consortium Symposium 2015: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(63 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Template:OHSU Rare Disease Research Consortium Symposium 2015}} | {{Template:OHSU Rare Disease Research Consortium Symposium 2015}} | ||
==General Info== | ==General Info== | ||
[http://www. | |||
Thank you all for your incredible interest in rare disease research. | |||
The OHSU Rare Disease Research Symposium 2015 brought together more than 200 participants including a selection of OHSU's top scientists to showcase our portfolio of rare disease research in “speed talks” plus a poster session/reception, along with a thought-provoking keynote address and special guest lectures. | |||
==Video Recording, Pictures and Further Information about the Symposium== | |||
:[https://echo360ess.ohsu.edu:8443/ess/portal/section/7adb441e-2b8e-490a-b219-9e2683611b5d Recording of the Symposium] use schedule listed below to locate presentations of interest. | |||
:[http://ohsuphotodesign.smugmug.com/Events/Rare-Disease-Conference-4715/n-sBQDdN/ Photos of the Symposium] | |||
;More info on the [[Media:HoatlinRDRC2015.pdf|OHSU Rare Disease Consortium]] | |||
;Contact person [https://www.linkedin.com/in/hoatlin Maureen Hoatlin, Ph.D.,MBA] (hoatlinm AT OHSU.edu) | |||
;Adding info frequently: [http://openwetware.org/wiki/OHSU_Rare_2015_Bonus_Materials Speaker Bios, cheatsheets and background reading] for the conference. | |||
==Sponsors== | |||
;A big Thank You for the support of this conference goes to: | |||
:[http://www.ohsu.edu/xd/education/schools/school-of-medicine/ The OHSU School of Medicine for a Collaborative Grant] | |||
:[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biochemistry-molecular-biology/ The OHSU Biochemistry and Molecular Biology Department] | |||
:[http://www.ohsu.edu/xd/research/techtransfer/ OHSU Technology Transfer and Business Development] | |||
:[http://www.ohsu.edu/xd/research/centers-institutes/octri/ OCTRI, the Oregon Clinical and Translational Research Institute] | |||
:OHSU Dean's Office, Communications. | |||
==Individual Thanks for Planning Help== | |||
:Valerie Scott, Biochemistry and Molecular Biology | |||
:Caroline Amling, Gerri Lutes OHSU Events | |||
:Rachel Shafer, OHSU Communications | |||
:[http://www.ohsu.edu/xd/education/library/about/staff-directory/jackie-wirz.cfm Jackie Wirz, Ph.D.] | |||
:Abby Dotson | |||
The Rare Disease Research Steering Committee: co-chairs Maureen Hoatlin & Susan Hayflick, Jit Banerjee, Maria Fleseriu, Bobby Heagerty, Penny Hogarth, Jonathan Lindner, Mark Pennisi, Sue Richards, Bob Steiner, Julie Earnest, Leila Schwanemann and Brittany Sale. | |||
== Schedule == | == Schedule == | ||
Line 18: | Line 44: | ||
|-- | |-- | ||
| 4:00-5:00 | | 4:00-5:00 | ||
| [http://www.kathiresanlab.org/about-sek/ Sekar Kathiresan, M.D.],Associate Professor of Medicine, | | [http://www.kathiresanlab.org/about-sek/ Sekar Kathiresan, M.D.], Associate Professor of Medicine,Harvard Medical School, Director of preventive cardiology at Massachusetts General Hospital | ||
Harvard Medical School, Director of preventive cardiology at Massachusetts General Hospital | |||
| Leveraging human knockouts to understand risk for and protection from disease | | Leveraging human knockouts to understand risk for and protection from disease | ||
|-- | |-- | ||
| 5:00 to 6:10 | | 5:00 to 6:10 | ||
| Poster session and reception | | Poster session and reception | ||
| 21 posters including a summary of the [[Media:HoatlinRDRC2015.pdf|OHSU Rare Disease Consortium]], plus a poster in remembrance of [http://www.oregonlive.com/opinion/index.ssf/2015/03/dave_frohnmayer_one_exceptiona.html#incart_story_package David Frohnmayer] where you will be able to share your memories of this extraordinary champion of rare disease research. | |||
|-- | |-- | ||
| 6:10 to 6:20 | | 6:10 to 6:20 | ||
Line 31: | Line 56: | ||
|-- | |-- | ||
| 6:20 to 6:30 | | 6:20 to 6:30 | ||
| Laura Hays, Ph.D., Executive Director, [http://fanconi.org Fanconi Anemia Research Fund] | | [https://www.linkedin.com/profile/view?id=137720697&authType=NAME_SEARCH&authToken=xOmu&locale=en_US&trk=tyah&trkInfo=clickedVertical%3Amynetwork%2Cidx%3A1-1-1%2CtarId%3A1428187934581%2Ctas%3Alaura Laura Hays, Ph.D.], Executive Director, [http://fanconi.org Fanconi Anemia Research Fund] | ||
| Making a difference: the David Frohnmayer advocacy formula | | Making a difference: the David Frohnmayer advocacy formula | ||
|-- | |-- | ||
| 6:30 to 6:35 | | 6:30 to 6:35 | ||
| [https://www.linkedin.com/in/hoatlin Maureen Hoatlin, Ph.D.,MBA], Associate Professor Biochemistry and Molecular Biology, co-chair OHSU Rare Disease Research Consortium | | [https://www.linkedin.com/in/hoatlin Maureen Hoatlin, Ph.D.,MBA], Associate Professor Biochemistry and Molecular Biology, co-chair OHSU Rare Disease Research Consortium | ||
| OHSU Rare Disease Consortium overview and | | OHSU Rare Disease Consortium overview and objectives of the symposium | ||
|-- | |-- | ||
Line 56: | Line 81: | ||
|-- | |-- | ||
| 7:10 to 7:20 | | 7:10 to 7:20 | ||
| [http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/molecular-and-medical-genetics/people/primary-faculty/cary-harding.cfm Cary Harding, M.D.] | | [http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/molecular-and-medical-genetics/people/primary-faculty/cary-harding.cfm Cary Harding, M.D.], Professor of Molecular and Medical Genetics and Pediatrics | ||
| Clinical trials in inborn errrors of amino acid and fatty acid metabolism | | Clinical trials in inborn errrors of amino acid and fatty acid metabolism | ||
|-- | |-- | ||
Line 66: | Line 91: | ||
|-- | |-- | ||
| 7:40 to 8:20 | | 7:40 to 8:20 | ||
| Xiaobing Quan, M.D., Ph.D, Executive Director, Translational Medicine at [http://www.regeneron.com Regeneron Pharmaceuticals, Inc.] | | [https://www.linkedin.com/profile/view?id=15675040&authType=NAME_SEARCH&authToken=SFpC&locale=en_US&trk=tyah&trkInfo=clickedVertical%3Amynetwork%2Cidx%3A1-3-3%2CtarId%3A1428187855309%2Ctas%3Axia Xiaobing Quan, M.D., Ph.D.], Executive Director, Translational Medicine at [http://www.regeneron.com Regeneron Pharmaceuticals, Inc.] | ||
| Accelerating opportunities from discovery to clinic in rare disease research | | Accelerating opportunities from discovery to clinic in rare disease research | ||
|-- | |-- | ||
Line 74: | Line 99: | ||
|-- | |-- | ||
|8:25 to 8:30 | |8:25 to 8:30 | ||
| | |[https://www.linkedin.com/profile/view?id=7275578&authType=NAME_SEARCH&authToken=gz7s&locale=en_US&trk=tyah&trkInfo=clickedVertical%3Amynetwork%2Cidx%3A1-1-1%2CtarId%3A1428093875533%2Ctas%3Atrish Trish Pruis, Ph.D.] | ||
|iPad Giveaway | |iPad Giveaway, random drawing of names of conference participants (must be present to win!) | ||
|} | |} | ||
</div> | </div> |
Latest revision as of 16:43, 5 May 2015
April 7, 2015, from 4-8:30 pm at OHSU in the Joseph Vey Conference Center
General InfoThank you all for your incredible interest in rare disease research. The OHSU Rare Disease Research Symposium 2015 brought together more than 200 participants including a selection of OHSU's top scientists to showcase our portfolio of rare disease research in “speed talks” plus a poster session/reception, along with a thought-provoking keynote address and special guest lectures. Video Recording, Pictures and Further Information about the Symposium
Sponsors
Individual Thanks for Planning Help
The Rare Disease Research Steering Committee: co-chairs Maureen Hoatlin & Susan Hayflick, Jit Banerjee, Maria Fleseriu, Bobby Heagerty, Penny Hogarth, Jonathan Lindner, Mark Pennisi, Sue Richards, Bob Steiner, Julie Earnest, Leila Schwanemann and Brittany Sale. Schedule
|